Literature DB >> 20607600

Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women's Healthy Eating and Living Study.

Cynthia A Thomson1, Cheryl L Rock, Patricia A Thompson, Bette J Caan, Ellen Cussler, Shirley W Flatt, John P Pierce.   

Abstract

The protective effect of vegetables on the risk of breast cancer recurrence is uncertain. We sought to evaluate the association between breast cancer recurrence and vegetable intake including analyses stratified on tamoxifen use. Experimental evidence of anti-carcinogenic activity of phytochemicals in cruciferous vegetables in combination with tamoxifen led to specific evaluation of this class of vegetables as well. To assess the association between vegetable intake and breast cancer recurrence, vegetable intake from repeat 24-h dietary recalls were examined as a secondary analysis of 3,080 breast cancer survivors enrolled in the Women's Healthy Eating and Living (WHEL) Study. At the time of enrollment women were, on average, 23.5 months post-diagnosis. The hazard of recurrence, controlling for relevant and significant clinical and demographic variables, with vegetable intake was assessed overall and separately for women taking tamoxifen. WHEL participants reported mean baseline intakes (⁻x, SE) of 3.1 ± 0.05 and 0.5 ± 0.02 servings/day of total and cruciferous vegetables, respectively. Baseline vegetable intake in the highest as compared to lowest tertiles was associated with an overall lower adjusted hazard ratios (HR) for recurrence of 0.69, 95% CI 0.55-0.87. Among women taking tamoxifen, the HRs were 0.56, 95% CI 0.41-0.77 for total vegetables and 0.65, 95% CI 0.47-0.89 for cruciferous vegetable intake. The hazard in women using tamoxifen who reported cruciferous vegetable intake above the median and who were within the highest tertile of total vegetable intake was HR 0.48; 95% CI 0.32-0.70. This secondary analysis in over 3,000 breast cancer survivors suggests that baseline vegetable intake may be associated with a reduction in the risk of breast cancer recurrent or new events particularly for those using tamoxifen. Such associations should be explored further as the possibility that vegetable intake is simply a surrogate for other health-promoting behaviors cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607600     DOI: 10.1007/s10549-010-1014-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.624


  27 in total

1.  Racial and ethnic differences in health status and health behavior among breast cancer survivors--Behavioral Risk Factor Surveillance System, 2009.

Authors:  Arica White; Lori A Pollack; Judith Lee Smith; Trevor Thompson; J Michael Underwood; Temeika Fairley
Journal:  J Cancer Surviv       Date:  2012-12-05       Impact factor: 4.442

Review 2.  Effects of complementary and integrative medicine on cancer survivorship.

Authors:  Moshe Frenkel; Victor Sierpina; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2015       Impact factor: 5.075

3.  Dietary Patterns in Puerto Rican and Mexican-American Breast Cancer Survivors: A Pilot Study.

Authors:  Cristina Palacios; Carrie R Daniel; Maribel Tirado-Gómez; Velda Gonzalez-Mercado; Liliana Vallejo; Jose Lozada; Alexis Ortiz; Daniel C Hughes; Karen Basen-Engquist
Journal:  J Immigr Minor Health       Date:  2017-04

4.  Postdiagnostic Fruit and Vegetable Consumption and Breast Cancer Survival: Prospective Analyses in the Nurses' Health Studies.

Authors:  Maryam S Farvid; Michelle D Holmes; Wendy Y Chen; Bernard A Rosner; Rulla M Tamimi; Walter C Willett; A Heather Eliassen
Journal:  Cancer Res       Date:  2020-11-15       Impact factor: 12.701

5.  The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics.

Authors:  Sarah J Nechuta; Bette J Caan; Wendy Y Chen; Shirley W Flatt; Wei Lu; Ruth E Patterson; Elizabeth M Poole; Marilyn L Kwan; Zhi Chen; Erin Weltzien; John P Pierce; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2011-06-28       Impact factor: 2.506

6.  Was race a factor in the outcomes of the Women's Health Eating and Living Study?

Authors:  Raheem J Paxton; Lovell A Jones; Shine Chang; Mike Hernandez; Richard A Hajek; Shirley W Flatt; Loki Natarajan; John P Pierce
Journal:  Cancer       Date:  2011-02-11       Impact factor: 6.860

7.  A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.

Authors:  Cynthia A Thomson; H H Sherry Chow; Betsy C Wertheim; Denise J Roe; Alison Stopeck; Gertraud Maskarinec; Maria Altbach; Pavani Chalasani; Chuan Huang; Meghan B Strom; Jean-Philippe Galons; Patricia A Thompson
Journal:  Breast Cancer Res Treat       Date:  2017-05-30       Impact factor: 4.872

Review 8.  Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies.

Authors:  Cynthia A Thomson; Emily Ho; Meghan B Strom
Journal:  Nutr Rev       Date:  2016-05-31       Impact factor: 7.110

9.  Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project.

Authors:  Sarah Nechuta; Bette J Caan; Wendy Y Chen; Marilyn L Kwan; Wei Lu; Hui Cai; Elizabeth M Poole; Shirley W Flatt; Wei Zheng; John P Pierce; Xiao Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-06-13       Impact factor: 4.254

10.  Dietary interventions for adult cancer survivors.

Authors:  Sorrel Burden; Debra J Jones; Jana Sremanakova; Anne Marie Sowerbutts; Simon Lal; Mark Pilling; Chris Todd
Journal:  Cochrane Database Syst Rev       Date:  2019-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.